ArticleOncotarget2017
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults.
Xinghua Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it